Casdin Capital Overview
- Investor Type
- Hedge Fund
- Status
- Active
- Professionals
- 8
- Investments
- 207
- Portfolio
- 99
- Exits
- 65
Casdin Capital General Information
Description
Founded in 2012, Casdin Capital is a hedge fund manager based in New York, New York. The firm primarily invests in companies operating in the biotechnology, healthcare, life science, information technology and industrial sectors.
Contact Information
Website
www.casdincapital.com
Year Founded
2012
Investor Status
Actively Seeking New Investments
Primary Investor Type
Hedge Fund
Other Investor Types
Venture Capital
Primary Office
- 1350 Avenue of the Americas
- Suite 2600
- New York, NY 10019
- United States
+1 (212) 000-0000
Casdin Capital Investments (207)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Creyon Bio | 08-Mar-2022 | Early Stage VC | 0000 | Drug Discovery | Pre-Clinical Trials | |
| 00000000 | 15-Feb-2022 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | |
| 000000 00000000000 | 09-Feb-2022 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | |
| 00000000 | 27-Jan-2022 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | |
| 000000 0000 | 25-Jan-2022 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | 000 000000 |
| 00000000 | 24-Jan-2022 | 0000 | 00000 | Biotechnology | Generating Revenue/Not Profitable | 000 000000 |
| 000 | 20-Jan-2022 | 00000 00000 | 0000 | Discovery Tools (Healthcare) | Generating Revenue/Not Profitable | 00000 000000000 00.0 |
| 00000 00000000000 | 19-Jan-2022 | 00000 00000 | 000.00 | Discovery Tools (Healthcare) | Generating Revenue | 00000 000000000 00.0 |
| Verana Health | 14-Jan-2022 | Later Stage VC | 00000 | Media and Information Services (B2B) | Generating Revenue | |
| Maze Therapeutics | 10-Jan-2022 | Early Stage VC | 00000 | Biotechnology | Generating Revenue |
Casdin Capital Exits (65)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Amunix Pharmaceuticals | 08-Feb-2022 | Merger/Acquisition | 00.000 |
| 000000000 000000 | 10-Dec-2021 | 000 | 000.00 |
| 0000000 | 01-Nov-2021 | 000 | 00000 |
| 0000000000 | 01-Oct-2021 | 000 | 00000 |
| 000000 00000000 00 | 30-Sep-2021 | 000 | 00000 |
| 000000 00000000 00 | 17-Sep-2021 | 0000000 000000 | 00.000 |
| 000000 00000000000 | 01-Sep-2021 | 000000000000000000 | 000.00 |
| 00000000000 | 30-Aug-2021 | 000000000000000000 | |
| Tango Therapeutics | 11-Aug-2021 | Reverse Merger | 00000 |
| Vividion Therapeutics | 01-Aug-2021 | Merger/Acquisition | 00.00 |
Casdin Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialCasdin Capital Team (21)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Evans Apeadu | Chief Financial Officer | New York, NY | |||
| Lawrence Canzoneri | Chief Financial Officer | New York, NY | |||
| Alexandria Fisk | Chief Operating Officer | New York, NY | |||
| Angelo Crupi | Chief Compliance Officer | New York, NY | |||
| Eli Casdin | Founder & Chief Investment Officer | 00 | 0 | 00 | New York, NY |
Casdin Capital Co-Investors (502)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| GV | 25 | 0 | 0 |
|
|
| Alexandria Venture Investments | 00 | 0 | 0 |
|
|
| Perceptive Advisors | 00 | 0 | 0 |
|
|
| Cormorant Asset Management | 00 | 0 | 0 |
|
|
| Fidelity Management & Research | 00 | 0 | 0 |
|
|